TINA ALBINO: Open Payments
NPI 1750921722 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 28 payments from 15 companies in 2025. Trend: 2023 $533 · 2024 $138 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 3 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| ABBVIE INC. | 3 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| Novo Nordisk Inc | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Lilly USA, LLC | 2 | $37 |
| EVOKE PHARMA, INC. | 2 | $35 |
| PFIZER INC. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $22 |
Products named: BRIXADI, REXULTI, RELISTOR, BREZTRI, LINZESS, GIMOTI, ELIQUIS, VRAYLAR.
Industry payments across FL — which companies pay providers there.
